- Advanced search
- Immuno Portal
- Malaria Portal
acamprosate is an approved drug (FDA (2004))
Compound class: Synthetic organic
Comment: Acamprosate is a NMDA glutamate receptor antagonist and a positive allosteric modulator of GABAA receptors.
Marketed formulations contain acamprosate calcium (PubChem CID 155434).
View more information in the IUPHAR Pharmacology Education Project: acamprosate